Our portfolio companies and our network partners are constantly looking for outstanding talent. Explore the open job positions below.
Didn't find what you were looking for? Tell us about your professional DNA to get discovered by any company in our network with opportunities relevant to your career goals.
Locations
Vienna, Austria · Vienna, Austria
industry
Biotechnology · DeepTech
Size
1 - 10 employees
Stage
Series A
founded in
2019
G.ST Antivirals is a clinical-stage biotech company focused on developing broad-spectrum antivirals for respiratory infections using an innovative host cell-based strategy. Founded in 2019 as a spin-off from the Medical University of Vienna, the company has developed a patented medication targeting rhinoviruses, the cause of the common cold. Their lead product, a 2-deoxyglucose nasal spray, has completed Phase 1 trials and is currently in Phase 2 studies. G.ST Antivirals aims to address significant medical needs in viral respiratory infections, with a unique approach that prevents resistance development, positioning itself strongly in the biotech market.
Something looks off?